Clinical trial
Combination Chemotherapy in Treating Patients With Stage III or Stage IV…
NCT00003346 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003346 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma |
| Official title | Phase I-II Trial of High-Dose Acetaminophen With Carmustine in Patients With Metastatic Melanoma |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Drug |
| Interventions | acetaminophen, acetylcysteine, carmustine |
| Enrollment | 80 |
| Start date | Nov 1, 1997 |
| Primary completion | Feb 1, 2003 |
| Completion | Feb 1, 2003 |
| First posted | Apr 25, 2003 |
| Last update posted | Jun 25, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: